pretickt

PODD financials

Insulet Corp. · end-of-day data as of Oct 16, 2026

Insulet Corp.
PODD · $9.79B
$141.10-13.6%last 60 sessions · close Oct 16, 2026
$130.47$346.3652 weeks
Buy · 26 analystsPT $186.67 +32.3%
  • P/E vs own-57.5%
  • P/E vs sector-6.3%
  • Target upside+32.3%
  • Off 52w high-59.3%
  • Insiders$162K
  • FCF yield+3.0%
  • Earnings in19d
  • Trendbearish
  • Sector▲ +16.0%
  • RSI56
  • MA20×50↑ in ~20d
  • Volume1.0x
  • Support-6.5%
  • Resistance0.0%

PODD reported revenue of $802M for the quarter ended Jun 30, 2026 (Q2 FY2026), up 23.5% from a year earlier. It posted diluted EPS of $1.37, free cash flow of $59.4M and a net margin of 11.8%.

Valuation

  • P/E26.4x
  • P/E vs own-57.5%
  • P/E vs sector-6.3%
  • FCF yield+3.0%
  • Market cap$9.79B

Quarterly results

Q2 FY2026: Revenue +23.5% year over year, free cash flow 7.4% of revenue, operating margin 16.2%.

RevenueFree cash flow
Q3 FY2023Q4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$802M1.37$59.4M70.2%16.2%11.8%
Q1 FY2026Mar 31, 2026$762M1.30$86M69.5%16.0%12.0%
Q4 FY2025Dec 31, 2025$784M1.44$48.2M72.5%18.7%13.0%
Q3 FY2025Sep 30, 2025$706M1.24$105M72.2%16.7%12.4%
Q2 FY2025Jun 30, 2025$649M0.32$173M69.7%18.7%3.5%
Q1 FY2025Mar 31, 2025$569M0.50$51.5M71.9%15.6%6.2%
Q4 FY2024Dec 31, 2024$598M1.39$91.7M72.1%18.3%16.9%
Q3 FY2024Sep 30, 2024$544M1.08$71.8M69.3%16.2%14.2%
Q2 FY2024Jun 30, 2024$489M2.59$64.3M67.7%11.2%38.6%
Q1 FY2024Mar 31, 2024$442M0.73$63.6M69.5%12.9%11.7%
Q4 FY2023Dec 31, 2023$510M1.48$47.2M70.9%20.9%20.3%
Q3 FY2023Sep 30, 2023$433M0.70$33.6M67.8%12.7%12.0%